• About

  • People

  • Portfolio

  • News

  • Contact

  • Careers

  • More

    Use tab to navigate through the menu items.

    News: Latest News

     
    Latest News
    Media Contact

    PRESS RELEASE

    NOV 14, 2021

    Aditum Bio Announces Formation of Motric Bio, Focused on Spasticity Associated with Neurological Injuries and Disease

    PRESS RELEASE

    AUG 31, 2021

    Versanis Bio Announces $70 million Series A Financing to Advance Bimagrumab for the Treatment of Obesity

    IN THE NEWS

    NOV 3, 2020

    Novartis vets Jimenez, Fishman thread digital into fabric of new VC firm Aditum, launch Tempero

    IN THE NEWS

    NOV 2, 2020

    Novartis alums Jimenez, Fishman unveil their next act: Aditum Bio

    PRESS RELEASE

    NOV 8, 2021

    Aditum Bio announces the appointment of Stephen Kanes, M.D. Ph.D., as Chief Executive Officer of Ancora Bio

    PRESS RELEASE

    JUN 30, 2021

    Aditum Bio Announces Formation of Ancora Bio, to Focus on Treatment-Resistant Depression

    PRESS RELEASE

    NOV 2, 2020

    Aditum Bio, Co-Founded by Novartis Veterans Joe Jimenez and Dr. Mark Fishman, forms Second Company

    IN THE NEWS

    NOV 2, 2020

    Joe Jimenez has one more thing to do in biopharma. And now he and Mark Fishman have a $133M stake to play the startup game

    PRESS RELEASE

    SEP 7, 2021

    Via Nova Therapeutics Announces $20 Million Series A Financing from Aditum Bio to Advance Four Antiviral Programs

    PRESS RELEASE

    DEC 15, 2020

    Aditum Bio Announces Formation of Third Company, Anteris Bio

    IN THE NEWS

    NOV 2, 2020

    Japan’s Sosei allies with ex-Novartis team to develop neurological drug pipeline

    IN THE NEWS

    NOV 2, 2020

    ‘Stealth’ VC firm Aditum Bio launches its second biotech startup

     
     
     
    MEDIA CONTACT

    ©2022 Aditum Bio. All Rights Reserved.

    Terms of Use
    Privacy
    Cookies
    Social
    Cal Compliance